Why the study?
What is the prevalence of coronary heart disease risk factors and metabolic syndrome in patients with chronic schizophrenia compared to the general population?
What is the prevalence of coronary heart disease risk factors and metabolic syndrome in patients with chronic schizophrenia compared to the general population?
Patients with chronic schizophrenia have a significantly higher prevalence of metabolic syndrome and elevated 10-year CHD risk compared to the general population, underscoring the need for cardiovascular screening.
Answers are grounded in this paper and cite their sources.
May warrant enhanced CHD screening in schizophrenia; extends cross-sectional prevalence data but leaves interventional questions open.
OBJECTIVE: To determine the prevalence and characteristics of coronary heart disease (CHD) risk factors in patients with chronic schizophrenia or schizoaffective disorder. METHOD: We compared individual CHD risk factors and Framingham risk predictions in a group of 240 patients with a large national sample (Canadian Heart Health Survey) matched for age and sex. In addition, we compared rates of the metabolic syndrome (syndrome X) with recently published rates in the US adult population. RESULTS: Compared with the reference population, Framingham 10-year risk of myocardial infarction was greater in the male patients (t3091 = 4.35, P < 0.001) but not in the female patients. Prevalence rates of the metabolic syndrome in the patients (42.6% of men and 48.5% of women) were approximately 2 times published rates in the US adult population. Further, the syndrome appears to occur at a younger age than in the general population. CONCLUSIONS: These long-term patients have increased CHD risks best captured by the metabolic syndrome conceptualization coupled with a high rate of cigarette smoking. This characterization is consistent with increased cardiovascular morbidity and decreased life expectancy in both men and women. We underscore the importance of both screening for and treating potentially reversible CHD risk factors in schizophrenia patients.
No takes yet. Share an insight, caveat, or question.
Cohn et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: